Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203547
Company: ZYDUS PHARMS
Company: ZYDUS PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DIFLUNISAL | DIFLUNISAL | 500MG | TABLET;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/16/2017 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203547Orig1s000ltr.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/28/2021 | SUPPL-1 | Labeling-Medication Guide, Labeling-Package Insert |
Label is not available on this site. |
DIFLUNISAL
TABLET;ORAL; 500MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DIFLUNISAL | DIFLUNISAL | 500MG | TABLET;ORAL | Prescription | No | AB | 202845 | HERITAGE PHARMA |
DIFLUNISAL | DIFLUNISAL | 500MG | TABLET;ORAL | Prescription | No | AB | 073673 | TEVA |
DIFLUNISAL | DIFLUNISAL | 500MG | TABLET;ORAL | Prescription | No | AB | 203547 | ZYDUS PHARMS |